Serial sections at specific sites along the length of the SR were analyzed by indirect immunohistochemistry using peroxidase-labeled anti-mouse or anti-sheep immunoglobulin secondary antibodies (Dako, Dakopatts, Denmark) as previously described.
41 The nine primary antibodies used, their specificities against the nine MyHCs expressed in EOMs are listed in
Table 1. Eight of these were monoclonal antibodies (mabs) and one was a polyclonal antibody. They were: (1) 10A10 with specificity against rabbit EO MyHC,
15 (2) 10F5 against 2B MyHC,
42 (3) 6H1 against 2X MyHC
42 (10F5 and 6H1, developed in our laboratory, are available from Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA, USA), (4) SC-71 against 2A MyHC in the rat,
43 but is specific for 2A/2X in rabbit,
32 (5) BA-G5 (from the American Type Culture Collection, Manassas, VA, USA) raised against cow atrium,
44 shown to react with rabbit α-cardiac MyHC,
15 (6) S58 (a generous gift from Frank E. Stockdale, MD, PhD) raised against chicken anterior latissimus dorsi (ALD),
45 but specific for β/slow MyHC in mammalian limb and EOM,
31 (7) NCL-MHCn (Novacastra Laboratories, Ltd., Newcastle-Upon-Tyne, UK) against rabbit neonatal MyHC,
15 (8) NCL-MHCd (from Novacastra) against rabbit embryonic MyHC,
15 and (9) a polyclonal antibody specific against slow-tonic MyHC described in the
Supplementary Data.
Table 1 also gives the simplified names of the antibodies (in parentheses) to be used hereafter, and the references documenting their specificities in the rabbit.